Product Information
RIZATRIPTAN 5 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.5163 per EA under NDC 68462046599. Its NADAC has been published 619 times since Nov 28, 2013.
FDA first approved this application on Dec 31, 2012.
Strength
5 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462046599
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
RIZATRIPTAN BENZOATEApproval Type
Generic (ANDA)
FDA Application
ANDA201967FDA Approved
12/31/2012
On Market Since
12/31/2012
Pharmacological Classes
Price Statistics
The NADAC for RIZATRIPTAN 5 MG TABLET has been published 619 times since Nov 28, 2013, and over the history we have for it it has declined 66.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5163 per EA |
|---|---|
| All-time high | $1.9320 (Feb 12, 2014) |
| All-time low | $0.3203 (Jul 17, 2024) |
| Median price | $0.8346 |
| Average price | $0.8563 |
| Largest weekly change | +74.4% (Aug 21, 2024) |
| Weeks tracked | 619 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+15.1%
5Y
-39.2%
All
-66.4%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
rizatriptan benzoate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RIZATRIPTAN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 5 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.5163 per EA (NDC 68462046599), effective Oct 1, 2025.
How has the price of RIZATRIPTAN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for RIZATRIPTAN 5 MG TABLET has declined 66.4%. It has been tracked across 619 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 5 MG TABLET?
Since Nov 28, 2013, the NADAC for RIZATRIPTAN 5 MG TABLET has ranged from a low of $0.3203 (Jul 17, 2024) to a high of $1.9320 (Feb 12, 2014), with a median of $0.8346 per EA.
Are there cheaper alternatives to RIZATRIPTAN 5 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RIZATRIPTAN 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures RIZATRIPTAN 5 MG TABLET?
RIZATRIPTAN 5 MG TABLET (NDC 68462046599) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.